CHARLOTTE, N.C., March 13, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today, pursuant to Nasdaq Marketplace Rule 4350, that the audit report contained in its Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission (SEC) on March 4, 2009, contained a going concern qualification.
